CHATTEM (NASDAQ:CHTT)
67.01
0.61 (0.9%)
| CHATTEM (NASDAQ:CHTT) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $67.62 | 52 Week High | $72.93 | ||
| Open | $67.52 | 52 Week Low | $50.10 | ||
| Day High | $67.52 | P/E | 15.48 | ||
| Day Low | $66.98 | EPS | $4.33 | ||
| Volume | 85,120 | ||||
| More CHTT Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| AA | 2 | RECN | 1 |
| MGI | 1 | FARO | 1 |
| SGR | 1 | TAP | 1 |
| VTR | 1 | RT | 1 |
| QCOM | 1 | FAZ | 1 |
| VALU | 1 | UHS | 1 |
Entities who have mentioned CHTT
- Jefferies & Co | View Related Stories »
- JPMorgan | View Related Stories »
- Citi | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Trading Radar | View Related Stories »
- Soleil Securities | View Related Stories »
- Goldman Sachs | View Related Stories »
- Wachovia | View Related Stories »
- Banc of America | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Jim Cramer | View Related Stories »
- Credit Suisse | View Related Stories »
- S&P Equity Research | View Related Stories »
- Piper Jaffray | View Related Stories »
- Matrix USA | View Related Stories »
- Calyon Securities | View Related Stories »
- Robert W Baird | View Related Stories »
- CL King | View Related Stories »
- ThinkEquity | View Related Stories »
- New Home Sales | View Related Stories »
- Pali Research | View Related Stories »
- Morgan Keegan & Company | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Goldman Sachs Conviction Sell List | View Related Stories »
View All Major News StreetInsider.com Major News for CHTT
- Chattem (CHTT) Reports Q3 Adj-EPS of $1.31, Beats by 10c; Reaffirms FY09 Outlook
- Chattem (CHTT) Reports Mixed Q2 Results; Affirms FY09 Outlook
- Chattem (CHTT) Misses Street's Q1 Views; Guides FY09 Above the Street
View All ReportsStreetInsider.com Reports on CHTT
- Chattem (CHTT) Reports Q3 Adj-EPS of $1.31, Beats by 10c; Reaffirms FY09 Outlook
- Trading Radar for 10/06: Yum! (YUM), Pepsi Bottling (PBG), Chattem (CHTT), AngioDynamics (ANGO) Report
- Morgan Stanley Initiates Coverage on Chattem (CHTT) with an Equalweight Rating
- Chattem (CHTT) Reports Mixed Q2 Results; Affirms FY09 Outlook
- Trading Radar for 7/9: Chevron (CVX), Shaw Group (SGR), 3Com (COMS), Chattem (CHTT), FCStone (FCSX) Report; Initial Claims, Wholesale Inventories Due
View All Press ReleasesCompany Press Releases on CHTT
- LecTec Corporation and Endo Pharmaceuticals Inc. Settle Patent Dispute
- Chattem Reports Increased Revenues and Earnings; Affirms Fiscal 2009 Guidance
StreetInsider Reports on CHTT by Category
View All BlogsBlogs on CHTT
- Forbes Best Small Companies for 2009: Part III
- Cramer's Mad Money - The Fastest Growing Drug Company (10/9/09)
- 10 Small to Mid Cap Stocks with Attractive Valuations
- Analyst upgrades, downgrades and initiations: ACI, HOT, LUV, QCOM, RTP, SAP ...
- 30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
View All FilingsSEC Filings on CHTT
- Form 4 STACY BILL W For: Oct 28
- Form 4 Chazen Gary D For: Oct 28
- Form 4 Brinkley Ruth W For: Oct 28
- Form 10-Q CHATTEM INC For: Aug 31
- Form 8-K CHATTEM INC For: Oct 06
Comments on CHTT
No comments are currently available.
